Anxiety
Medical Cannabis and Chronic Pain
Medical Cannabis and Epilepsy
Medical Cannabis and Multiple Sclerosis
Insomnia
Chemotherapy Induced Nausea and Vomiting
Inflammatory Bowel Disease
Medical Cannabis and Palliative Care
Chronic Pain (non-cancer)
Multiple Sclerosis
Medical Cannabis Studies
Medical Cannabis in Australia
Depression
Medical Cannabis and Epilepsy Syndromes
Endometriosis
Arthritis
Parkinson’s Disease
Cancer Pain
Post Traumatic Stress Disorder
Chemotherapy Induced Nausea and Vomiting
Autism Spectrum Disorder
Migraine
Clinical Practice Guidelines for Cannabis and Cannabinoid-Based Medicines in the Management of Chronic Pain and Co-Occurring Conditions
Mary Ann Liebert Inc. April 2024
Cannabis for chronic pain: cardiovascular safety in a nationwide Danish study
European Heart Journal. Feb 2024
Thoughtfully Integrating Cannabis Products Into Chronic Pain Treatment
Anesthesia & Analgesia. Jan 2024
Real-Life Experience With Purified Cannabidiol Treatment for Refractory Epilepsy: A Multicenter Retrospective Study
Pediatric Neurology. Jan 2024
Potential Drug Interactions with Cannabinoids in Selected Chronic Diseases: Epilepsy, Autism Spectrum Disorders, Oncology, Multiple Sclerosis and Pain
Medicine and Pharmacology. Feb 2024
Clinical Practice Guidelines for Cannabis and Cannabinoid-Based Medicines in the Management of Chronic Pain and Co-Occurring Conditions
Cannabis and Cannabinoid Research 2024
Cannabis for medical use versus opioids for chronic non-cancer pain: a systematic review and network meta-analysis of randomised clinical trials
BMJ Open 2024
Cannabis for chronic pain: cardiovascular safety in a nationwide Danish study
European Heart Journal 2024
Therapeutic applicability of cannabidiol and other phytocannabinoids in epilepsy, multiple sclerosis and Parkinson’s disease and in comorbidity with psychiatric disorders
Basic and Clinical Pharmacology and Toxicology 2024
Real-Life Experience With Purified Cannabidiol Treatment for Refractory Epilepsy: A Multicenter Retrospective Study
Pediatric Neurology 2024
Potential Drug Interactions with Cannabinoids in Selected Chronic Diseases: Epilepsy, Autism Spectrum Disorders, Oncology, Multiple Sclerosis and Pain
Pharmaceuticals 2024
Multifaceted targets of cannabidiol in epilepsy: Modulating glutamate signaling and beyond
Computers in Biology and Medicine 2024
Decoding epilepsy treatment: A comparative evaluation contrasting cannabidiol pharmacokinetics in adult and paediatric populations
Chemico-Biological Interactions 2024
Dissecting the role of cannabinoids in vascular health and disease
Journal of Cellular Physiology 2024
A critical assessment of the abuse, dependence and associated safety risks of naturally occurring and synthetic cannabinoids
Frontiers in Psychiatry 2024
Cannabinoids for Cancer-related Pain Management: An Update on Therapeutic Applications and Future Perspectives
Anticancer Research 2024
Cannabis and Cannabinoids in Adults with Cancer: ASCO Guideline
Journal of Clinical Oncology 2024
Safety and effectiveness of cannabinoids to Danish patients with treatment refractory chronic pain—A retrospective observational real-world study
European Journal of Pain 2022
ASRA Pain Medicine consensus guidelines on the management of the perioperative patient on cannabis and cannabinoids
BMJ 2022
Cannabinoids versus placebo for pain: A systematic review with meta-analysis and Trial Sequential Analysis
Plos One 2023
Cannabinoids as a Potential Alternative to Opioids in the Management of Various Pain Subtypes: Benefits, Limitations, and Risks
Pain and Therapy 2023
Disorders of cancer metabolism: The therapeutic potential of cannabinoids
Biomedicine and Pharmacotherapy 2023
Specific cannabinoids revive adaptive immunity by reversing immune evasion mechanisms in metastatic tumours
Frontiers in Immunology 2023
Therapeutic Potential of Minor Cannabinoids in Dermatological Diseases—A Synthetic Review
Molecules 2023
Cannabidiol for the Treatment of Brain Disorders: Therapeutic Potential and Routes of Administration
Pharmaceutical Research 2023
How long does a single oral dose of cannabidiol persist in plasma? Findings from three clinical trials
Drug Testing and Analysis 2023
Medical Cannabis Use Patterns for Sleep Disorders in Australia: Results of the Cross-Sectional CAMS-20 Survey
Nature and Science of Sleep 2023
Medicinal cannabis for psychiatry-related conditions: an overview of current Australian prescribing
Frontiers in Pharmacology 2023
Tetrahydrocannabinol and Cannabidiol in Tourette Syndrome
NEJM Evidence 2023
Pharmacotherapy, alternative and adjunctive therapies for eating disorders: findings from a rapid review
Journal of Eating Disorders 2023
Long-term cannabidiol treatment for seizures in patients with tuberous sclerosis complex
Epilepsia 2021
Oral liquid cannabidiol (Epidyolex) for Dravet syndrome
NPS Medicinewise 2021
Cannabis-based products for pediatric epilepsy: A systematic review
Epilepsia 2019
Add-on Cannabidiol Treatment for Drug-Resistant Seizures in Tuberous Sclerosis Complex
JAMA Neurology 2021
Neurobiology of Cannabinoids and Medical Cannabis in Therapeutic Intervention for Multiple Sclerosis: Understanding the Molecular Mechanisms of Action
Book Chapter, 2023
Medical Cannabis in the Treatment of Parkinson’s Disease
Clinical Neuropharmacology, 2023
Licensed Medical Cannabis Use in Gilles de la Tourette Syndrome: A Retrospective Long-term Follow-Up
Cannabis and Cannabinoid Research, May 2023
Clinical Outcome Data of Children Treated with Cannabis-Based Medicinal Products for Treatment Resistant Epilepsy
Neuropediatrics, 2023
Cannabis-Responsive Biomarkers: A Pharmacometabolomics-Based Application to Evaluate the Impact of Medical Cannabis Treatment on Children with Autism Spectrum Disorder
Cannabis and Cannabinoid Research, 2023
Clinical outcome data of chronic pain patients treated with cannabis-based oils and dried flower from the UK Medical Cannabis Registry
Expert Review of Neurotherapeutics, Apr 2023
Transmucosal delivery of the medical Cannabis oil via a nanoemulsion formulation
Journal of Drug Delivery Science and Technology, Jan 2023
Use of Medical Cannabis by Patients With Cancer: Attitudes, Knowledge, and Practice
Journal of Pain and Symptom Management May 2023
The use of medical cannabis concomitantly with immune checkpoint inhibitors in non-small cell lung cancer: A sigh of relief?
European Journal of Cancer Feb 2023
The effect of medical cannabis in inflammatory bowel disease
Expert Review of Gastroenterology & Hepatology Dec 2022
Medicinal cannabis for pain: Real-world data on three-month changes in symptoms and quality of life
Sage Journals 2023
Medical Cannabis Use Patterns for Sleep Disorders in Australia
Nature and Science of Sleep 2023
Sex Differences in the Pharmacokinetics of Cannabidiol and Metabolites Following Oral Administration of a Cannabidiol-Dominant Cannabis Oil in Healthy Adults
Cannabis and Cannabinoid Research 2023
[Tetrahydrocannabinol (THC) in patients with fibromyalgia syndrome (FMS) : A retrospective study of changes in pain, psychometric variables, and analgesic consumption during inpatient interdisciplinary multimodal pain therapy (IMPT)]
Clinical outcome data of anxiety patients treated with cannabis-based medicinal products in the United Kingdom: a cohort study from the UK Medical Cannabis Registry
Psychopharmacology 2023
CANNA-TICS: Efficacy and safety of oral treatment with nabiximols in adults with chronic tic disorders
Psychiatric Research 2023
The effect of medical cannabis in inflammatory bowel disease: analysis from the UK Medical Cannabis Registry
Clinical Practice Guidelines for Cannabis and Cannabinoid-Based Medicines in the Management of Chronic Pain and Co-Occurring Conditions
Medication sparing after medical cannabis initiation: A case study of a chronic pain patient in Project Twenty21
The effect of medical cannabis in inflammatory bowel disease: analysis from the UK Medical Cannabis Registry
Expert Review of Gastroenterology and Hepatology. January 2023
CBG: A compound with medical potiential
Project CBD November 2022
A large Australian registry demonstrates sustained safety and efficacy of oral medicinal cannabis for at least two years
PLoS ONE November 2022
A large Australian longitudinal cohort registry demonstrates sustained safety and efficacy of oral medicinal cannabis for at least two years
Plos One. November 2022.
CBG: A compound with intriguing medical potential
Project CBD. November 2022
New Developments in Cannabis Medicine – Dr Bonni Goldstein
Interview: Project CBD
Cannabidiol and the Changing Perspective of Epilepsy Drug Discovery
“Is medical cannabis safe for my patients?” A practical review of cannabis safety considerations
European Journal of Internal Medicine. 2021
Medical cannabis or cannabinoids for chronic pain: a clinical practice guideline
BMJ 2021
Medical cannabis or cannabinoids for chronic non-cancer and cancer related pain: a systematic review and meta-analysis of randomised clinical trials
BMJ 2021
A Phase 1, Randomised, Placebo‑Controlled, Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of Cannabidiol in Fed Healthy Volunteers
European Journal of Drug Metabolism and Pharmacokinetics. 2020
Antiseizure Effects of Cannabidiol Leading to Increased Peroxisome Proliferator-Activated Receptor Gamma Levels in the Hippocampal CA3 Subfield of Epileptic Rats
Pharmaceuticals (2022)
Improved cognition impairment by activating cannabinoid receptor type 2: Modulating CREB/BDNF expression and impeding TLR-4/ NFκBp65/M1 microglia signaling pathway in D-galactose-injected ovariectomized rats
PLoS ONE (March 2022)
Motor‑like Tics are Mediated by CB2 Cannabinoid Receptor‑dependent and Independent Mechanisms Associated with Age and Sex
Molecular Neurobiology (2022)
Editorial: Tribute to Professor Raphael Mechoulam, The Founder of Cannabinoid and Endocannabinoid Research
Molecules (2022)
New Insights and Potential Therapeutic Targeting of CB2 Cannabinoid Receptors in CNS Disorders
This review addresses recent advances on the role of CB2Rs in neuropsychiatric and neurodegenerative disorders, including, but not limited to, anxiety, depression, schizophrenia, Parkinson’s disease (PD), Alzheimer’s disease (AD), Huntington’s disease (HD) and addiction. International Journal of Molecular Sciences. (2022)
Detection of Cannabinoid Receptor Expression by Endometriotic Lesions in Women with Endometriosis as an Alternative to Opioid-Based Pain Medication
Results suggest that ovarian endometriotic lesions express CB1 and CB2 receptors, and these lesions may respond to cannabinoids as pain medication. Journal of Immunology Research (2022)
Special Issue Editorial: Cannabinoid signalling in the brain: New vistas
This special issue intends to bring together a series of empirical papers, targeted reviews and opinions from leaders in the field that will highlight the new advances in cannabinoid research. European Journal of Neuroscience (2022)
Vitamin D mitigates diabetes-associated metabolic and cognitive dysfunction by modulating gut microbiota and colonic cannabinoid receptor 1
Targeting gut microbiota by Vit D could be a successful strategy in the treatment of diabetes and associated cognitive deficit. European Journal of Pharmaceutical Sciences (2022)
Neurobiology of cannabinoid receptor signaling
Dialogues in Clinical Neuroscience (2020)
Identification of an Orally Bioavailable, Brain-Penetrant Compound with Selectivity for the Cannabinoid Type 2 Receptor
Molecules (2022)
Cannabinoid interventions for improving cachexia outcomes in cancer: a systematic review and meta-analysis
The effectiveness of cannabinoids alone to improve outcomes of CAC remains unclear. Low-quality evidence from both RCTs and NRSIs shows no significant benefits of cannabinoids for weight gain, appetite stimulation, and better quality of life, three important outcomes of cachexia.
Journal of Cachexia, Sarcopenia and Muscle (2022)
Clinical management of cannabis withdrawal
This review describes the diagnosis, prevalence, course and management of cannabis withdrawal and highlights opportunities for future clinical research.
Addiction Oct 2021
Efficacy and safety of medical cannabinoids in children: a systematic review and meta-analysis
Scientific Reports, Dec 2021
Cannabidiol for COVID-19 Patients with Mild to Moderate Symptoms
Cannabis and Cannabinoid Research
2021
The Effects of Cannabis on Female Reproductive Health Across the Life Course
Cannabis and Cannabinoid Research
2021
A Review of Hemp as Food and Nutritional Supplement
Cannabis and Cannabinoid Research
2021
Perceived Efficacy, Reduced Prescription Drug Use, and Minimal Side Effects of Cannabis in Patients with Chronic Orthopaedic Pain
Cannabis and Cannabinoid Research
2021
Motor‑like Tics are Mediated by CB2 Cannabinoid Receptor‑dependent and Independent Mechanisms Associated with Age and Sex
Gorberg V, Borisov V, Greig IR, Pertwee RG, McCaffery P, Anavi-Goffer S.
Molecular Neurobiology 2022
Tribute to Professor Raphael Mechoulam, The Founder of Cannabinoid and Endocannabinoid Research
Mauro Maccarrone
Molecules 2022
New Insights and Potential Therapeutic Targeting of CB2 Cannabinoid Receptors in CNS Disorders
Kibret BG, Ishiguro H, Horiuchi Y, and Onaivi ES.
International Journal of Molecular Science 2022
Identification of an Orally Bioavailable, Brain-Penetrant Compound with Selectivity for the Cannabinoid Type 2 Receptor
Ospanov M, Sulochana SP, Paris JJ, Rimoldi JM, Ashpole N, Walker L, Ross SA, Shilabin AG, and Ibrahim MA.
Molecules 2022
Neurobiology of cannabinoid receptor signaling
Lutz, Beat.
Dialogues in Clinical Neuroscience 2020
Expert advice for prescribing cannabis medicines for patients with epilepsy—drawn from the Australian clinical experience
British Journal of Clinical Pharmacology 2022
Detection of Cannabinoid Receptor Expression by Endometriotic Lesions in Women with Endometriosis as an Alternative to Opioid-Based Pain Medication
Sarah Allam, S., Paris, E., Lazcano, I., Bitterman, P., Basu, S., O’Donnell, J., and Barua.
Journal of Immunology Research 2022
Vitamin D mitigates diabetes-associated metabolic and cognitive dysfunction by modulating gut microbiota and colonic cannabinoid receptor 1
Hebatallah M. Hussein, Mohammed F. Elyamany, Laila A. Rashed, Nada A. Sallam
European Journal of Pharmaceutical Sciences 2021
Improved cognition impairment by activating cannabinoid receptor type 2: Modulating CREB/BDNF expression and impeding TLR-4/ NFκBp65/M1 microglia signaling pathway in D-galactose-injected ovariectomized rats
Sahar S. Abd El-Rahman, Hany M. Fayed.
Plos One 2022
Cannabinoid signalling in the brain
Busquets-Garcia, A.,Melis, M., Bellocchio, L., and Marsicano, G.
European Journal of Neuroscience. 2022
Antiseizure Effects of Cannabidiol Leading to Increased Peroxisome Proliferator-Activated Receptor Gamma Levels in the Hippocampal CA3 Subfield of Epileptic Rats
Costa, A.M., Russo, F., Senn, L., Ibatici, D., Cannazza, G., and Biagini, G.
Pharmaceuticals 2022
Cannabinoid interventions for improving cachexia outcomes in cancer
Simon, L., Baldwin, C., Kalea, A.Z., and Slee, A.
Journal of Cachexia, Sarcopenia and Muscle (2022)
Clinical management of cannabis withdrawal
Connor, J.P., Stjepanovi, D., Budney, A.J., Le Foll, B., and Hall, W.D.
Addiction. 2022 (Article)
The safety, tolerability, and effectiveness of PTL-101, an oral cannabidiol formulation, in pediatric intractable epilepsy: A phase II, open-label, single-center study
Mitelpunkt, A., Kramer, U., Hausman Kedem, M., Zilbershot Fink, E., Orbach, R., Cheruha, V., Fattal-Valevski, A., Deutsch, L., Heffetz, D., Sacks, H.
Epilepsy & Behavior 2019 (Article)
Single-Dose Pharmacokinetics of Oral Cannabidiol Following Administration of PTL101:A New Formulation Based on Gelatin Matrix Pellets Technology
Atsmon, J., Heffetz, D., Deutsch, L., Deutsch, F., Sacks, H.
Clinical Pharmacology in Drug Development 2017 (Article)
Substitution of medical cannabis for pharmaceutical agents for pain, anxiety, and sleep
Piper BJ, DeKeuster RM, Beals ML, Cobb CM, Burchman CA, Perkinson L, Lynn ST, Nichols SD, Abess AT
Journal of Psychopharmacology 2017 (Article)
Practical Considerations in Medical Cannabis Administration and Dosing
MacCallum CA, Russo EB
European Journal of Internal Medicine Jan 2018 (Article)
Medical Cannabis for Older Patients
Minerbi A, Häuser W, Fitzcharles M-A
Drugs & Aging Nov 2018 (Article)
Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review
Sarris J, Sinclair J, Karamacoska D, Davidson M, Firth J
BMC Psychiatry Jan 2020 (Article)
Considerations for the Use of Medical Cannabis: An Overview of Benefits and Harms
Shakya DR, Upadhaya SR, Neupane H, Subedi R
Biomedical Journal of Scientific & Technical Research Jun 2021 (Article)
Cannabidiol use and effectiveness: real-world evidence from a Canadian medical cannabis clinic
Rapin L, Gamaoun R, El Hage C, Arboleda MF, Prosk E
Journal of Cannabis Research Jun 2021 (Article)
Cannabinoid therapy in epilepsy
Billakota S, Devinsky O, Marsh E
Current Opinion in Neurology Apr 2019 (Abstract)
Medical Cannabis for Intractable Epilepsy in Childhood: A Review
Ben-Zeev B
Rambam Maimonides Medical Journal Jan 2020 (Article)
Cannabis-based products for pediatric epilepsy: An updated systematic review
Elliott J, DeJean D, Clifford T, Coyle D, Potter BK, Skidmore B, Alexander C, Repetski AE, Shukla V, McCoy B, Wells GA
seizure European Journal of Epilepsy Feb 2020 (Article)
Guidance for the use of medicinal cannabis for the prevention or management of nausea and vomiting in Australia
Therapeutic Goods Administration 2017 (Article)
Top Ten Tips Palliative Care Clinicians Should Know About Medical Cannabis
Briscoe J, Kamal AH, Casarett DJ
Journal of Palliative Medicine 2019 (Article)
A critical narrative review of medical cannabis in pediatrics beyond epilepsy, part lll: chemotherapy-induced nausea and vomiting and inflammatory bowel disease
Simonian JS, Varanasi S, Richards GJ, Nguyen AV, Diaz-Fong JP, Le J
Pediatric Medicine 2020 (Article)
Medicinal cannabis: Nausea and Vomiting – Evidence Summary
NPS MedicineWise May 2020 (Article)
Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial
Grimison P, Mersiades A, Kirby A, Lintzeris N, Morton R, Haber P, Olver I, Walsh A, McGregor I, Cheung Y, Tognela A, Hahn C, Briscoe K, Aghmesheh M, Fox P, Abdi E, Clarke S, Della-Fiorentina S, Shannon J, Gedye C, Begbie S, Simes J, Stockler M
Annals of Oncology Nov 2020 (Article)
Medicinal Cannabis in Oncology: a Valuable Unappreciated Remedy or an Undesirable Risk?
Abu-Amna M, Salti T, Idan C, Khoury M, Bar-Sela G
Current Treatment Options in Oncology Feb 2021 (Article)
Medicinal cannabis use in palliative care
Herbert A, Hardy J
Australian Journal of General Practice Jun 2021 (Article)
Medicinal Cannabis Use In Oncology
Bodine M, Kemp AK
StatPearls Internet Jan 2022 (Article)
State of the evidence: Cannabinoids and cancer pain – A Systematic Review
Tateo S
Journal of the American Association of Nurse Practitioners Feb 2017 (Abstract)
A selective review of medical cannabis in cancer pain management
Blake A, Wan BA, Malek L, DeAngelis C, Diaz P, Lao N, Chow E, O’Hearn S
Annals of Palliative Medicine Aug 2017 (Article)
Principles of cancer pain management: An overview and focus on pharmacological and interventional strategies
Yoong J, Poon P
Australian Journal of General Practice Nov 2018 (Article)
Update on cannabis and cannabinoids for cancer pain
Chung M, Kim HK, Abdi S
Current Opinion in Anaesthesiology Dec 2020 (Article)
The endocannabinoid system of the skin in health and disease: novel perspectives and therapeutic opportunities
Bíró T, Tóth BI, Haskó G, Paus R, Pacher P
Trends in Pharmacological Sciences Aug 2009 (Abstract)
Medicinal Cannabis in the Palliation of Malignant Wounds – A Case Report
Maida V
Journal of Pain and Symptom Management Oct 2016
Topical Medicinal Cannabis: A New Treatment for Wound Pain – Three Cases of Pyoderma Gangrenosum
Maida V, Corban J
Journal of Pain and Symptom Management Nov 2017 (Article)
Effects of cannabidiol, a cannabis sativa constituent, on oral wound healing
Klein M, De Quadros de Bortolli J, Borghetti RL, Jacoby LS, Salum FG, Cherubini K, Zancanaro de Figueiredo M
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology Jan 2020 (Abstract)
Topical cannabis-based medicines – A novel paradigm and treatment for non-uremic calciphylaxis leg ulcers: An open label trial
Maida V, Shi RB, Fazzari FGT, Zomparelli L
International Wound Journal Jul 2020 (Article)
The therapeutic potential of cannabinoids for integumentary wound management
Weigelt MA, Sivamani R, Lev-Tov H
Experimental Dermatology Nov 2020 (Article)
Promoting wound healing of uremic calciphylaxis leg ulcers using topical cannabis-based medicines
Maida V, Shi RB, Fazzari FGT, Zomparelli L
Dermatologic Therapy Nov 2020 (Preview)
A new treatment paradigm for sickle cell disease leg ulcers: Topical cannabis-based medicines
Maida V, Shi RB, Fazzari FGT, Zomparelli L-M
Experimental Dermatology Dec 2020 (Article)
“Less pain with more gain” – Managing wound-related pain with cannabis-based medicines
Maida V, Biasi SA
Wound Repair and Regeneration Jan 2021 (Abstract)
Topical cannabis-based medicines – A novel adjuvant treatment for venous leg ulcers: An open-label trial
Maida V, Shi RB, Fazzari FGT, Zomparelli L
Experimental Dermatology May 2021 (Abstract)
Cannabinoid-based drugs targeting CB1 and TRPV1, the sympathetic nervous system, and arthritis
Lowin T, Straub RH
Arthritis Research & Therapy Sep 2015 (Article)
Cannabis and joints: scientific evidence for the alleviation of osteoarthritis pain by cannabinoids
O’Brien M, McDougall JJ
Current Opinion in Pharmacology Jun 2018 (Abstract)
Medical cannabis and cannabinoids in rheumatology: where are we now?
Sarzi-Puttini P, Batticciotto A, Atzeni F, Bazzichi L, Di Franco M, Salaffi F, Marotto D, Ceribelli A, Ablin JN, Hauser W
Expert Review of Clinical Immunology Oct 2019 (Abstract)
Cannabis Use among Older Persons with Arthritis, Cancer and Multiple Sclerosis: Are We Comparing Apples and Oranges?
Kaskie B, Kang H, Bhagianadh D, Bobitt J
brain sciences Apr 2021 (Article)
Medicinal cannabis for inflammatory bowel disease: real-life experience of mode of consumption and assessment of side-effects
Naftali T, Bar-Lev Schleider L, Sklerovsky Benjaminov F, Lish I, Konikoff FM, Ringel Y
European Journal of Gastroenterology & Hepatology Nov 2019 (Abstract)
Cannabis for the Treatment of Inflammatory Bowel Disease: A True Medicine or a False Promise?
Naftali T, Dor M
Rambam Maimonides Medical Journal Jan 2020 (Article)
Medicinal Cannabis for Inflammatory Bowel Disease: A Survey of Perspectives, Experiences, and Current Use in Australian Patients
Benson MJ, Abelev SV, Connor SJ, Corte CJ, Martin LJ, Gold LK, Suraev AS, McGregor IS
Crohn’s & Colitis 360 Apr 2020 (Article)
Cannabis in Gastroenterology: Watch Your Head! A Review of Use in Inflammatory Bowel Disease, Functional Gut Disorders, and Gut-Related Adverse Effects
Nasser Y, Woo M, Andrews CN
Current Treatment Options in Gastroenterology Nov 2020 (Article)
Inflammatory Bowel Disease and Cannabis: A Practical Approach for Clinicians
Buckley MC, Kumar A, Swaminath A
Advances in Therapy Jun 2021 (Article)
Cannabis, Cannabinoids, and Sleep: a Review of the Literature
Babson KA, Sottile J, Morabito D
Current Psychiatry Reports: Sleep Disorders Mar 2017 (Article)
Medical Cannabis and the Treatment of Obstructive Sleep Apnea: An American Academy of Sleep Medicine Position Statement
Ramar K, Rosen IM, Kirsch DB, Chervin RD, Carden KA, Aurora RN, Kristo DA, Malhotra RK, Martin JL, Olson EJ, Rosen CL, Rowley JA
Journal of Clinical Sleep Medicine Apr 2018 (Article)
Acute effect of vaporized Cannabis on sleep and electrocortical activity
Mondino A, Cavelli M, González J, Santana N, Castro-Zaballa S, Mechoso B, Bracesco N, Fernandez S, Garcia-Carnelli C, Castro MJ, Umpierrez E, Murillo-Rodriguez E, Torterolo P, Falconi A
Pharmacology, Biochemistry and Behavior Feb 2019 (Article)
The use of cannabinoids for sleep: A critical review on clinical trials
Kuhathasan N, Dufort A, MacKillop J, Gottschalk R, Minuzzi L, Frey BN
Experimental and Clinical Psychopharmacology 2019 (Abstract)
Medical cannabis and cannabinoids for impaired sleep: a systematic review and meta-analysis of randomized clinical trials
AminiLari M, Wang L, Neumark S, Adli T, Couban RJ, Giangregorio A, Carney CE, Busse JW
Sleep Feb 2022 (Abstract)
The Clinical Significance of Endocannabinoids in Endometriosis Pain Management
Bouaziz J, Bar On A, Seidman DS, Soriano D
Cannabis and Cannabinoid Research Apr 2017 (Article)
Self-Reported Efficacy of Cannabis for Endometriosis Pain
Reinert AE, Hibner M
Journal of Minimally Invasive Gynecology Nov 2019 (Abstract)
Managing endometriosis pain with cannabis
Schwartz B
Contemporary OB/GYN Dec 2019 (Article)
Cannabis Use, a Self-Management Strategy Among Australian Women With Endometriosis: Results From a National Online Survey
Sinclair J, Smith CA, Abbott J, Chalmers KJ, Pate DW, Armour M
Journal of Obstetrics and Gynaecology Canada Mar 2020 (Abstract)
Endometriosis – an indication for cannabinoids?
Nahler G
Traditional Medicine Jul 2020 (Article)
Cannabinoids and chronic pelvic pain in women: Focus on endometriosis
Marcu I, Gee A, Lynn B
Journal of Endometriosis and Pelvic Pain Disorders Jul 2021 (Abstract)
Medical Cannabis for Neuropathic Pain
Lee G, Grovey B, Furnish T, Wallace M
Current Pain and Headache Reports Feb 2018 (Abstract)
Cannabis products for adults with chronic neuropathic pain
Mücke M, Phillips T, Radbruch L, Petzke F, Häuser W
Cochrane Mar 2018 (Abstract)
Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal cannabis cohort
Baron EP, Lucas P, Eades J, Hogue O
The Journal of Headache and Pain May 2018 (Article)
Effect of cannabis use in people with chronic non-cancer pain prescribed opioids: findings from a 4-year prospective cohort study
Campbell G, Hall WD, Peacock A, Lintzeris N, Bruno R, Larance B, Nielsen S, Cohen M, Chan G, Mattick RP, Blyth F, Shanahan M, Dobbins T, Farrell M, Degenhardt L
The Lancet Jul 2018 (Article)
Cannabis and cannabinoids for the treatment of people with chronic noncancer pain conditions: a systematic review and meta-analysis of controlled and observational studies
Stockings E, Campbell G, Hall WD, Nielsen S, Zagic D, Rahman R, Murnion B, Farrell M, Weier M, Degenhardt L
Pain Oct 2018 (Abstract)
The effectiveness of self-directed medical cannabis treatment for pain
Xiaoxue L, Vigil JM, Stith SS, Brockelman F, Keeling K, Hall B
Complementary Therapies in Medicine Oct 2019 (Abstract)
Evaluation of the effects of CBD hemp extract on opioid use and quality of life indicators in chronic pain patients: a prospective cohort study
Capano A, Weaver R, Burkman D
Postgraduate Medicine Nov 2019 (Article)
The pharmacokinetics, efficacy, and safety of a novel selective-dose cannabis inhaler in patients with chronic pain: A randomized, double-blinded, placebo-controlled trial
Almog S, Aharon-Peretz J, Vulfsons S, Ogintz M, Abalia H, Lupo T, Hayon Y, Eisenberg E
European Journal of Pain May 2020 (Article)
No pain, all gain? Interim analysis from a longitudinal, observational study examining the impact of medical cannabis treatment on chronic pain and related symptoms
Gruber SA, Smith RT, Dahlgren MK, Lambros AM, Sagar KA
Experimental and Clinical Psychopharmacology 2021 (Abstract)
Medical cannabis or cannabinoids for chronic pain: a clinical practice guideline
Busse JW, Vankrunkelsven P, Zeng L, Heen AF, Merglen A, Campbell F, Granan L-P, Aertgeerts B, Buchbinder R, Coen M, Juurlink D, Samer C, Siemieniuk RAC, Kumar N, Cooper L, Brown J, Lytvyn L, Zeraatkar D, Wang L, Guyatt GH, Vandvik PO, Agoritsas T
The BMJ Sep 2021 (Article)
Experiences with medical cannabis in the treatment of veterans with PTSD: Results from a focus group discussion
Krediet E, Janssen DGA, Heerdink ER, Egberts TCG, Vermetten E
European Neuropsychopharmacology Jul 2020 (Article)
Short and Long-Term Effects of Cannabis on Symptoms of Post-Traumatic Stress Disorder
LaFrance EM, Glodosky NC, Bonn-Miller M, Cuttler C
Journal of Affective Disorders Sep 2020 (Article)
Evidence for Use of Cannabinoids in Mood Disorders, Anxiety Disorders, and PTSD: A Systematic Review
Stanciu CN, Brunette MF, Teja N, Budney AJ
Psychiatry online Feb 2021 (Abstract)
The Effectiveness of Cannabis Flower for Immediate Relief from Symptoms of Depression
Li X, Diviant JP, Stith SS, Brockelman F, Keeling K, Hall B, Vigil JM
Yale Journal of Biology and Medicine Jun 2020 (Article)
Cannabis and Depression
Feingold D, Weinstein A
Cannabinoids and Neuropsychiatric Disorders Dec 2020 (Abstract)
The Use of Medical Cannabis in the Treatment Comorbid Anxiety and Depression
Mechtler L, Ralyea C, Hart P, Bargnes V
Neurology Apr 2021 (Abstract)
Antidepressant and Anxiolytic Effects of Medicinal Cannabis Use in an Observational Trial
Martin EL, Strickland JC, Schlienz NJ, Munson J, Jackson H, Bonn-Miller MO, Vandrey R
frontiers in Psychiatry Sep 2021 (Article)
Patient-Reported Symptom Relief Following Medical Cannabis Consumption
Stith SS, Vigil JM, Brockelman F, Keeling K, Hall B
frontiers in Pharmacology Aug 2018 (Article)
A naturalistic examination of the perceived effects of cannabis on negative affect
Cuttler C, Spradlin A, McLaughlin RJ
Journal of Affective Disorders Aug 2018 (Article)
Cannabinoid Regulation of Fear and Anxiety: an Update
Papagianni EP, Stevenson CW
Anxiety Disorders Apr 2019 (Article)
Cannabidiol in Anxiety and Sleep: A Large Case Series
Shannon S, Lewis N, Lee H, Hughes S
The Permanente Journal Jul 2019 (Article)
Reduction of Benzodiazepine Use in Patients Prescribed Medical Cannabis
Purcell C, Davis A, Moolman N, Taylor SM
Cannabis and Cannabinoid Research Sep 2019 (Article)
Use of cannabidiol in anxiety and anxiety-related disorders
Skelley JW, Deas CM, Curren Z, Ennis J
Journal of the American Pharmacists Association Jan 2020 (Abstract)
The ”Entourage Effect”: Terpenes Coupled with Cannabinoids for the Treatment of Mood Disorders and Anxiety Disorders
Ferber Goldstein S, Namdar D, Hen-Shoval D, Eger G, Koltai H, Shoval G, Shbiro L, Weller A
Current Neuropharmacology Feb 2020 (Abstract)
Cannabis use among US adults with anxiety from 2008 to 2017 The role of state-level cannabis legalization
Weinberger AH, Zhu J, Levin J, Barrington-Trimis JL, Copeland J, Wyka K, Kim JH, Goodwin RD
Drug and Alcohol Dependence Sep 2020 (Abstract)
Cannabis, a cause for anxiety? A critical appraisal of the anxiogenic and anxiolytic properties
Sharpe L, Sinclair J, Kramer A, de Manincor M, Sarris J
Journal of Translational Medicine Oct 2020 (Article)
Cannabis use in people with Parkinson’s disease and Multiple Sclerosis: A web-based investigation
Kindred JH, Kaigang L, Ketelhut NB, Proessl F, Fling BW, Honce JM, Shaffer WR, Rudroff T
Complementary Therapies in Medicine Aug 2017 (Abstract)
The Use of Cannabis and Cannabinoids in Treating Symptoms of Multiple Sclerosis: a Systematic Review of Reviews
Nielsen S, Germanos R, Weier M, Pollard J, Degenhardt L, Hall W, Buckley N, Farrell M
Neurology of Systemic Diseases Feb 2018 (Abstract)
Assessment of Efficacy and Tolerability of Medicinal Cannabinoids in Patients With Multiple Sclerosis: A Systematic Review and Meta-analysis
Torres-Moreno MC, Papaseit E, Torrens M, Farre M
JAMA Network Open Oct 2018 (Article)
The dark side of the moon: looking beyond beneficial effects of cannabis use in multiple sclerosis
Penner I-K, Hartung H-P
Brain Sep 2019 (Article)
The anti-inflammatory and analgesic effects of formulated full-spectrum cannabis extract in the treatment of neuropathic pain associated with multiple sclerosis
Maayah ZH, Takahara S, Ferdaoussi M, Dyck JRB
Inflammation Research Apr 2020 (Abstract)
Patterns of Medical Cannabis Use among Patients Diagnosed with Multiple Sclerosis
Guarnaccia JB, Khan A, Ayettey R, Treu JA, Comeford B, Njike VY
Multiple Sclerosis and Related Disorders May 2021 (Abstract)
Endocannabinoid System and Migraine Pain: An Update
Greco R, Demartini C, Zanaboni AM, Piomelli D, Tassorelli C
frontiers in Neuroscience Mar 2018 (Article)
Short- and Long-Term Effects of Cannabis on Headache and Migraine
Cuttler C, Spradlin A, Cleveland MJ, Craft RM
The Journal of Pain May 2020 (Article)
Migraine Frequency Decrease Following Prolonged Medical Cannabis Treatment: A Cross-Sectional Study
Aviram J, Vysotski Y, Berman P, Lewitus GM, Eisenberg E, Meiri D
Brain Sciences Jun 2020 (Article)
Alleviative effects of Cannabis flower on migraine and headache
Stith SS, Diviant JP, Brockelman F, Keeling K, Hall B, Lucern S, Vigil JM
Journal of Integrative Medicine Sep 2020 (Abstract)
Medical Cannabis, Headaches, and Migraines: A Review of the Current Literature
Poudel S, Quinonez J, Choudhari J, Au ZT, Paesani S, Thiess AK, Ruxmohan S, Hosameddin M, Ferrer GF, Michel J
Cureus Aug 2021 (Article)
The Case for Cannabis: The Evidence for Treating Migraine with Cannabis
Sexton M
Emergency Medicine News Sep 2021 (Article)
Endocannabinoid Signaling in Autism
Chakrabarti B, Persico A, Battista N, Maccarrone M
Neurotherapeutics Jul 2015 (Article)
Brief Report: Cannabidiol-Rich Cannabis in Children with Autism Spectrum Disorder and Severe Behavioral Problems – A Retrospective Feasibility Study
Aran A, Cassuto H, Lubotzky A, Wattad N, Hazan E
Journal of Autism and Developmental Disorders Oct 2018 (Abstract)
Real life Experience of Medical Cannabis Treatment in Autism: Analysis of Safety and Efficacy
Schleider LB-L, Mechoulam R, Saban N, Meiri G, Novack V
Scientific Reports Jan 2019 (Article)
Effects of cannabidiol on brain excitation and inhibition systems; a randomised placebo-controlled single dose trial during magnetic resonance spectroscopy in adults with and without autism spectrum disorder
Pretzsch CM, Freyberg J, Voinescu B, Lythgoe D, Horder J, Mendez MA, Wichers R, Ajram L, Ivin G, Heasman M, Edden RAE, Williams S, Murphy DGM, Daly E, McAlonan GM
Neuropsychopharmacology Feb 2019 (Article)
Cannabidiol as a suggested candidate for treatment of autism spectrum disorder
Poleg S, Golubchik P, Offen D, Weizman A
Progress in Neuro-Psychopharmacology and Biological Psychiatry Mar 2019 (Abstract)
Current state of evidence of cannabis utilization for treatment of autism spectrum disorders
Agarwal R, Burke SL, Maddux M
BMC Psychiatry Oct 2019 (Article)
Effects of CBD-Enriched Cannabis sativa Extract on Autism Spectrum Disorder Symptoms: An Observational Study of 18 Participants Undergoing Compassionate Use
Fleury-Teixeira P, Caixeta FV, da Silva LCR, Brasil-Neto JP, Malcher-Lopes R
frontiers in Neurology Oct 2019 (Article)
Autism Spectrum Disorder and Medical Cannabis: Review and Clinical Experience
Mostafavi M, Gaitanis J
Seminars in Pediatric Neurology Oct 2020 (Abstract)
Cannabinoid treatment for autism: a proof-of-concept randomized trial
Aran A, Harel M, Cassuto H, Polyansky L, Schnapp A, Wattad N, Shmueli D, Golan D, Castellanos FX
Molecular Autism Feb 2021 (Article)
Symptoms, adverse events, and outcomes in the use of medicinal cannabis in children and adolescents with autism spectrum disorder: a scoping review protocol
Fletcher S, Pawliuk C, Ip A, Oberlander T, Siden H
JBI Evidence Synthesis May 2021 (Article)
Safety and Efficacy of Medical Cannabis in Autism Spectrum Disorder Compared with Commonly Used Medications
Holdman R, Vigil D, Robinson K, Shah P, Contreras AE
Mary Ann Liebert Inc publishers Aug 2021 (Abstract)
Cannabinoids in Parkinson’s Disease
Bassi MS, Sancesario A, Morace R, Centonze D, Iezzi E
Cannabis and Cannabinoid Research 2017 (Article)
Cannabinoids in the Treatment of Parkinson’s Disease
Gandor F, Ebersbach G
Neurology International Open 2017 (Article)
Cannabis use in people with Parkinson’s Disease and Multiple Sclerosis: A web-based investigation
Kindred JH, Li K, Ketelhut NB, Proessl F, Fling BW, Honce JM, Shaffer WR, Rudroff T
Complementary Therapies in Medicine Aug 2017 (Abstract)
Pros and Cons of Marijuana in Treatment of Parkinson’s Disease
Patel RS, Kamil S, Shah MR, Bhimanadham NN, Imran S
Cureus Jun 2019 (Article)